In this issue:
Brentuximab vedotin pre-alloSCT for R/R CD30+ lympho-proliferative disorders
Outcomes in CLL patients who discontinue ibrutinib
Combined modality treatment in early-stage HL
Expert pathologic review of lymphoma diagnosis
Final results of the IELSG-19 trial of mucosa-associated lymphoid tissue lymphoma
Early PET–adapted treatment in HL
CAR T-cells lymphoma remission associated with high serum IL-15
Idarubicin dose escalation during consolidation for AML
VR-CAP vs R-CHOP for newly diagnosed MCL
Improved outcomes for myeloid leukaemia of Down syndrome
Please login below to download this issue (PDF)